OncoMed Pharmaceuticals, Inc. (OMED)

IPO News
IPO Profile
  • Scheduled
  • 05/11/12
  • $115.0 mm
  • n/a
  • Jefferies & Co.
    Leerink Swann
  • Piper Jaffray

  • All Underwriters
Business
  • Biotech developing new antibody therapeutics used in cancer treatments.
  • Health-Drugs
  • 83
  • 2004
OMED Daily
 
Corporate Data
  • 800 Chesapeake Drive
    Redwood City, CA
  • 650-995-8200
  • www.oncomed.com